Trials / Completed
CompletedNCT03254966
Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients
Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II Study to Assess the Safety and Efficacy of SHR0302 in Patients With Moderate to Severe Active Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 194 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of SHR0302 tablets (SHR0302) in subjects with moderate to severe active rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0302 | Oral tablets |
| DRUG | Placebo | Oral tablets |
Timeline
- Start date
- 2017-11-24
- Primary completion
- 2019-04-16
- Completion
- 2019-10-12
- First posted
- 2017-08-21
- Last updated
- 2021-09-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03254966. Inclusion in this directory is not an endorsement.